Company Filing History:
Years Active: 2018
Title: **Brian Schrader: Innovator in Nucleic Acid Detection**
Introduction
Brian Schrader is a prominent inventor based in Austin, TX, known for his significant contributions in the field of molecular biology. With a unique focus on innovations surrounding nucleic acid detection, he has developed methods that stand to enhance the accuracy and efficiency of biological research.
Latest Patents
Brian Schrader holds one patent that showcases his inventive prowess. The patent, titled "Hydrolysis Probes - Methods and Compositions for the Detection and Quantification of Nucleic Acids," presents a novel approach for detecting and quantifying target nucleic acids. The method involves contacting a sample with a primer and a probe designed for hybridization with the target nucleic acid. Notably, this probe incorporates a fluorophore and is affixed to a solid support. This innovative technique allows for the release and detection of a reporter signal, enabling the quantification of the target nucleic acid through a decrease in signal intensity.
Career Highlights
Brian is currently employed at Luminex Corporation, where his expertise plays a crucial role in the company's advancements in detection technologies. His work contributes to the ongoing development of solutions that are essential for various applications in diagnostics and research.
Collaborations
Throughout his career, Brian has had the privilege of collaborating with skilled professionals in his field, including his coworkers Douglas Whitman and Douglas F. Whitman. These collaborations further enhance the impact of his innovations, fostering an environment of creativity and knowledge sharing.
Conclusion
In summary, Brian Schrader's contributions as an inventor continue to influence the landscape of molecular detection technologies. With his patent on hydrolysis probes, he stands at the forefront of innovations that promise to improve the accuracy of nucleic acid assays, ultimately advancing research and diagnostic capabilities. His role at Luminex Corporation and collaborations with other experts highlight his dedication and commitment to scientific advancement.